REVOLUTION MEDICINES INC (RVMD)
US76155X1000 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 696.15M | 161.40M | 108.50M | 104.30M | 16.70M | |||
| Marketable Securities | 1.16B | 483.50M | 468.60M | 336.50M | 106.10M | |||
| Receivables | 1.25M | 4.70M | 5.90M | 6.40M | 8.70M | |||
| Other Current Assets | 25.07M | 10.60M | 6.80M | 7.00M | 2.50M | |||
| Total Current Assets | 1.88B | 660.20M | 589.80M | 454.10M | 134.00M | |||
| Non-Current Assets | ||||||||
| PPE Net | 100.01M | 73.70M | 71.20M | 36.30M | 7.10M | |||
| Goodwill | 14.61M | 14.60M | 14.60M | 14.60M | 14.60M | |||
| Intangibles | 57.74M | 58.80M | 59.90M | 60.90M | 62.00M | |||
| Other Non-Current Assets | 10.06M | 4.60M | 2.50M | 1.40M | 2.80M | |||
| Total Non-Current Assets | 182.42M | 151.70M | 148.20M | 113.30M | 86.50M | |||
| TOTAL ASSETS | 2.06B | 811.90M | 738.00M | 567.40M | 220.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | 200.00K | |||
| Accrued Expenses | 78.17M | 35.70M | 33.60M | 22.40M | 12.90M | |||
| Accounts Payable | 61.79M | 21.30M | 14.10M | 12.60M | 11.40M | |||
| Other Current Liabilities | 3.90M | 5.00M | 12.70M | 12.20M | 18.60M | |||
| Total Current Liabilities | 143.85M | 62.00M | 60.40M | 47.20M | 43.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | 3.12M | 7.00M | 7.40M | 7.40M | 7.80M | |||
| Other Non-Current Liabilities | 88.55M | 57.70M | 67.60M | 38.10M | 17.10M | |||
| Total Non-Current Liabilities | 91.66M | 64.70M | 75.00M | 45.50M | 24.90M | |||
| TOTAL LIABILITIES | 235.51M | 126.70M | 135.40M | 92.70M | 68.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.14B | -701.30M | -452.60M | -265.50M | -157.40M | |||
| Additional Paid In Capital | 2.96B | 1.39B | 1.06B | 740.10M | 4.70M | |||
| Common Shares | 16.00K | 0.00 | 0.00 | 0.00 | 305.10M | |||
| Shares Outstanding | 164.67M | 90.50M | 74.10M | 66.60M | 59.00M | |||
| Tangible Book Value per Share | 10.65 | 6.76 | 7.13 | 5.99 | -3.88 | |||
| Total Shareholders' Equity | 1.83B | 685.20M | 602.60M | 474.70M | 152.50M | |||
| TOTAL LIABILITIES AND EQUITY | 2.06B | 811.90M | 738.00M | 567.40M | 220.50M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 13.06 | 10.65 | 9.76 | 9.62 | 3.11 | |||
| Return On Assets (ROA) | -21.17% | -30.63% | -25.35% | -19.45% | -28.07% | |||
| Return On Equity (ROE) | -23.89% | -36.30% | -31.05% | -23.25% | -40.59% | |||
All data in USD